New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look.

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...

Importantly, the drug enables systemic metabolic effects while ... supportive care therapy for cancer patients suffering from anorexia and weight loss. Currently, there is no FDA-approved treatment ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

In the third quarter, sales of the cancer drug Verzenio soared by 32% year over year to $1.4 billion. Newer products like ...

W hen president-elect Donald Trump announced that he would nominate Robert F Kennedy Jr to be his secretary of Health and Human Services, the move shocked many. Kennedy, the son of the late senator ...

JACC is publishing two secondary analyses on the impact of GLP-1 medications in improving cardiac structure ... Tirzepatide has already been FDA approved for weight loss. Researchers looked at 106 ...